These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3835045)

  • 41. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
    Gregersen G; Frederiksen G
    Ugeskr Laeger; 1971 Jul; 133(29):1406-9. PubMed ID: 5569040
    [No Abstract]   [Full Text] [Related]  

  • 42. [True hepatic Wilson's disease].
    Ciravegna B; Giacchino R; Marazzi MG
    Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 44. [Wilson's disease ("hepatic form") in a region endemic for schistosomiasis mansoni: clinical presentation of 25 patients].
    Galizzi-Filho J; Andrade Mde O; Cota Mde M; Penna FJ; Figueiredo-Filho PP; Valadares CA; Machado-Silva R; Barquete J; de Oliveira JP; de Almeida JA
    Arq Gastroenterol; 1998; 35(1):11-7. PubMed ID: 9711308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [2 cases of Wilson's disease with hepatic precession in biliary lithiasis].
    Dupuy R; Vallin J; Fabiani F
    Rev Int Hepatol; 1969; 19(4):233-40. PubMed ID: 5404531
    [No Abstract]   [Full Text] [Related]  

  • 46. Neuromuscular transmission and acetylcholine receptor antibodies in penicillamine-treated Wilson's disease patients.
    Anlar B; Kuruoğlu R; Varli K; Topçu M
    Muscle Nerve; 1996 May; 19(5):676-7. PubMed ID: 8618573
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pregnancy and delivery in a woman with Wilson's disease (degeneratio hepatoleuticularis)].
    Pierzchała W; Zamłyński J; Rzempołuch J
    Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):200-1. PubMed ID: 8084826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Possible accidents due to penicillamine during treatment of Wilson's disease].
    Boudin G; Pépin B
    Bull Acad Natl Med; 1972 May; 156(12):375-9. PubMed ID: 4572368
    [No Abstract]   [Full Text] [Related]  

  • 49. [Wilson's disease (hepatolenticular degeneration)].
    Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M
    Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518
    [No Abstract]   [Full Text] [Related]  

  • 50. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Wilson's disease].
    Bonfissuto G; Magliarisi C; Soresi M; Bascone F; Costanza G; Carroccio A; Montalto G
    Recenti Prog Med; 1997 Jan; 88(1):40-5. PubMed ID: 9102715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years].
    Alexiou D; Hatzis T; Koutselinis A
    Arch Fr Pediatr; 1985; 42(6):447-9. PubMed ID: 4051676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurologic symptoms improve in patients with Wilson's disease despite immunosuppression.
    Schumacher G; Mueller AR; Platz KP; Neuhaus R; Bechstein WO; Becker M; Luck W; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3099-100. PubMed ID: 8962200
    [No Abstract]   [Full Text] [Related]  

  • 54. [Wilson's disease: seven cases with hepatic onset (author's transl)].
    Pigrau Serrallach C; Pahissa Berga A; Clotet Sala B; Guardia Massó J
    Med Clin (Barc); 1981 Nov; 77(9):367-70. PubMed ID: 7329147
    [No Abstract]   [Full Text] [Related]  

  • 55. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
    Lange J; Brandt G
    Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
    [No Abstract]   [Full Text] [Related]  

  • 56. Studies in pancreatic secretion: VIII. Pancreatic function in patients with Wilson's disease.
    Dreiling DA; Grateron H
    Mt Sinai J Med; 1983; 50(4):335-7. PubMed ID: 6196633
    [No Abstract]   [Full Text] [Related]  

  • 57. Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
    Farinati F; Cardin R; Mestriner C; Sturniolo GC; Naccarato R
    Am J Gastroenterol; 1995 Dec; 90(12):2264-5. PubMed ID: 8540540
    [No Abstract]   [Full Text] [Related]  

  • 58. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 59. [The organic psycho-syndrome in Wilson's disease (longterm follow-up with psychologic testing in 4 patients during d-penicillamin-therapy) (author's transl)].
    Hayek HW; Knoll E; Widhalm S
    Monatsschr Kinderheilkd (1902); 1973 Nov; 121(11):679-83. PubMed ID: 4358747
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; ROSEVEAR JW; McGUCKIN WF
    Trans Am Neurol Assoc; 1961; 86():131-4. PubMed ID: 13899919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.